日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma

对不可切除的肝细胞癌患者进行酪氨酸激酶抑制剂联合抗PD-1抗体治疗后的转化疗法后行肝切除术

Zhu, Xiao-Dong; Huang, Cheng; Shen, Ying-Hao; Xu, Bin; Ge, Ning-Ling; Ji, Yuan; Qu, Xu-Dong; Chen, Lingli; Chen, Yi; Li, Mei-Ling; Zhu, Jin-Jin; Tang, Zhao-You; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan

Simulation of portal/hepatic vein associated remnant liver ischemia/congestion by three-dimensional visualization technology based on preoperative CT scan

基于术前CT扫描的三维可视化技术模拟门静脉/肝静脉相关残余肝脏缺血/淤血

Li, Xiao-Long; Xu, Bin; Zhu, Xiao-Dong; Huang, Cheng; Shi, Guo-Ming; Shen, Ying-Hao; Wu, Dong; Tang, Min; Tang, Zhao-You; Zhou, Jian; Fan, Jia; Sun, Hui-Chuan

NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma

NT5DC2通过稳定EGFR促进肝细胞癌中的肿瘤细胞增殖

Li, Kang-Shuai; Zhu, Xiao-Dong; Liu, Hong-Da; Zhang, Shi-Zhe; Li, Xiao-Long; Xiao, Nan; Liu, Xue-Feng; Xu, Bin; Lei, Ming; Zhang, Yuan-Yuan; Shi, Wen-Kai; Cao, Man-Qing; Xu, Yun-Fei; Tang, Zhao-You; Sun, Hui-Chuan

Targeting angiogenesis for liver cancer: Past, present, and future

靶向血管生成治疗肝癌:过去、现在和未来

Zhu, Xiao-Dong; Tang, Zhao-You; Sun, Hui-Chuan

Adverse effects of chemoradiotherapy on invasion and metastasis of tumor cells

放化疗对肿瘤细胞侵袭和转移的不良影响

Xiong, Wei; Liao, Yong; Qin, Ji-Yong; Li, Wen-Hui; Tang, Zhao-You

miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features.

miR-192-5p 基因异常沉默是具有癌症干细胞特征的肝细胞癌的关键事件

Gu Yuanzhuo, Wei Xiyang, Sun Yulin, Gao Hongjun, Zheng Xin, Wong Linda L, Jin Ling, Liu Niya, Hernandez Brenda, Peplowska Karolina, Zhao Xiaohang, Zhan Qi-Min, Feng Xin-Hua, Tang Zhao-You, Ji Junfang

Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization

预测肝细胞癌患者对经动脉化疗栓塞治疗反应的基因特征

Fako, Valerie; Martin, Sean P; Pomyen, Yotsawat; Budhu, Anuradha; Chaisaingmongkol, Jittiporn; Franck, Sophia; Lee, Joyce Man-Fong; Ng, Irene Oi-Lin; Cheung, Tan-To; Wei, Xiyang; Liu, Niya; Ji, Junfang; Zhao, Lei; Liu, Zhaogang; Jia, Hu-Liang; Tang, Zhao-You; Qin, Lun-Xiu; Kloeckner, Roman; Marquardt, Jens; Greten, Tim; Wang, Xin Wei

Correction: MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma

更正:血清和肿瘤组织中microRNA-34a的表达水平可以预测肝细胞癌患者的骨转移。

Xiang, Zuo-Lin; Zhao, Xiao-Mei; Zhang, Li; Yang, Ping; Fan, Jia; Tang, Zhao-You; Zeng, Zhao-Chong

Renin-angiotensin inhibitors were associated with improving outcomes of hepatocellular carcinoma with primary hypertension after hepatectomy

肾素-血管紧张素抑制剂与肝切除术后原发性高血压合并肝细胞癌患者的预后改善相关。

Feng, Long-Hai; Sun, Hui-Chuan; Zhu, Xiao-Dong; Zhang, Shi-Zhe; Li, Kang-Shuai; Li, Xiao-Long; Li, Yan; Tang, Zhao-You

Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a

更正:miR-182-5p 通过抑制 FOXO3a 促进肝细胞癌进展

Cao, Man-Qing; You, A-Bin; Zhu, Xiao-Dong; Zhang, Wei; Zhang, Yuan-Yuan; Zhang, Shi-Zhe; Zhang, Kei-Wei; Cai, Hao; Shi, Wen-Kai; Li, Xiao-Long; Li, Kang-Shuai; Gao, Dong-Mei; Ma, De-Ning; Ye, Bo-Gen; Wang, Cheng-Hao; Qin, Cheng-Dong; Sun, Hui-Chan; Zhang, Ti; Tang, Zhao-You